Aradigm
HomeAboutProductsTechnologiesInvestorsCareers
Press Releases

Press Releases

All Releases
Aradigm to Hold Business Update Conference Call on July 16
Jul 09, 2008
Aradigm to Hold Business Update Conference Call on July 16 HAYWARD, Calif.--(BUSINESS WIRE)--July 9, 2008--Aradigm Corporation (OTCBB: ARDM) (the "Company"), a specialty pharmaceutical company, today announced it will hold a business update conference call on Wednesday, July 16, 2008 at 11:00 a.m.
Aradigm Reports Successful Top-line Phase 2 Data with Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis
Jun 30, 2008
Study demonstrates significant reduction in bacterial infection and improvement in lung function following two weeks of treatment. Once daily dosing regimen may bring added convenience to patients
Aradigm Initiates Phase 2 Study of Inhaled Liposomal Ciprofloxacin in Bronchiectasis
Jun 19, 2008
Study Will Explore New Treatment of a Severe Respiratory Disease Condition with Unmet Medical Need
Aradigm Announces First Quarter 2008 Financial Results
May 14, 2008
Aradigm Announces First Quarter 2008 Financial Results HAYWARD, Calif., May 14, 2008 (BUSINESS WIRE) -- Aradigm Corporation (OTCBB:ARDM) (the "Company") today announced financial results for the first quarter ended March 31, 2008. The Company reported no revenues for the three months ended March
Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated with AERx(R) Insulin Diabetes Management System (iDMS)
Apr 30, 2008
Preclinical and Clinical Data Supports Lung Safety of AERx(R) iDMS
Webcast Alert: Lippert/Heilshorn Life Sciences Virtual Conference (Aradigm)
Apr 17, 2008
Webcast Alert: Lippert/Heilshorn Life Sciences Virtual Conference (Aradigm) NEW YORK, Mar 17, 2008 (BUSINESS WIRE) -- Aradigm (ARDM) announces the following Webcast: What: Lippert/Heilshorn Life Sciences Virtual Conference When: March 18, 2008 @ 11:30 AM Eastern Where:
Aradigm Initiates Trial of Lung Rx's Inhaled Treprostinil
Apr 08, 2008
Bridging Study Compares AERx Essence(R) System to Nebulizer Used in Phase 3 TRIUMPH trial
Aradigm Announces Fourth Quarter 2007 and Full Year Financial Results
Mar 25, 2008
Company Advances Development Programs for Severe Respiratory Disease
Aradigm to Hold 2007 Fourth Quarter Financial Results Conference Call March 25
Mar 18, 2008
Aradigm to Hold 2007 Fourth Quarter Financial Results Conference Call March 25 HAYWARD, Calif.--(BUSINESS WIRE)--March 18, 2008--Aradigm Corporation (OTCBB:ARDM) (the "Company"), a specialty pharmaceutical company, will release its 2007 fourth quarter financial results after the market close on
Aradigm to Present at BIO CEO & Investor Conference 2008 on February 13
Feb 04, 2008
Webcast Scheduled February 13 at 12:30 P.M. Eastern Time
Aradigm to Hold Business Update Conference Call Today at 4:30 EST
Jan 16, 2008
Aradigm to Hold Business Update Conference Call Today at 4:30 EST HAYWARD, Calif., Jan 16, 2008 (BUSINESS WIRE) -- Aradigm Corporation (OTCBB:ARDM) (the "Company"), a specialty pharmaceutical company, will hold a business update conference call today at 4:30 p.m. Eastern (1:30 p.m. Pacific).
Aradigm Appoints Timothy Lynch to Board of Directors
Jan 02, 2008
Aradigm Appoints Timothy Lynch to Board of Directors HAYWARD, Calif.--(BUSINESS WIRE)--Jan. 2, 2008--Aradigm Corporation (OTCBB:ARDM) today announced it appointed Timothy Lynch to its board of directors. Mr. Lynch served as the Chief Financial Officer of biopharmaceutical company Tercica and before
Aradigm Initiates Phase 2 Study of Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis
Nov 19, 2007
Specialty Product Advances Following Successful Phase 1 Trial
Aradigm Announces Third Quarter 2007 Financial Results
Nov 18, 2007
Company Advances Development Programs for Severe Respiratory Disease
Aradigm CEO Igor Gonda to Be Interviewed Live on WallSt.Net
Oct 31, 2007
Aradigm CEO Igor Gonda to Be Interviewed Live on WallSt.Net HAYWARD, Calif., Oct 31, 2007 (BUSINESS WIRE) -- Aradigm Corporation (OTCBB:ARDM) (the "Company") today announced that the Company's President and Chief Executive Officer, Igor Gonda, Ph.D. will be featured in a live interview to be
Aradigm to Present at the Rodman & Renshaw Acumen BioFin 9th Annual Healthcare Conference on November 7
Oct 30, 2007
Aradigm to Present at the Rodman & Renshaw Acumen BioFin 9th Annual Healthcare Conference on November 7 HAYWARD, Calif.--(BUSINESS WIRE)--Oct. 30, 2007--Aradigm Corporation (OTCBB:ARDM) (the "Company") today announced that President and Chief Executive Officer Igor Gonda, Ph.D.
Aradigm to Hold 2007 Third Quarter Financial Results Conference Call November 8
Oct 25, 2007
Aradigm to Hold 2007 Third Quarter Financial Results Conference Call November 8 HAYWARD, Calif.--(BUSINESS WIRE)--Oct. 25, 2007--Aradigm Corporation (OTCBB: ARDM) (the "Company"), a specialty pharmaceutical company, will release its 2007 third quarter financial results after the market close on
Aradigm Corporation Reports Initial Human Data on a Novel Approach to Treatment of Tobacco Smoking Addiction Using its AERx Essence(R) Nicotine Inhaler
Oct 25, 2007
Phase 1 Data Presented at the National Conference on Tobacco or Health in Minneapolis
Aradigm to Present at Merriman Curhan Ford's 4th Annual Investor Summit on September 17
Sep 10, 2007
Aradigm to Present at Merriman Curhan Ford's 4th Annual Investor Summit on September 17 HAYWARD, Calif.--(BUSINESS WIRE)--Sept. 10, 2007--Aradigm Corporation (OTCBB:ARDM) today announced that President and Chief Executive Officer Igor Gonda, Ph.D. will present at the Merriman Curhan Ford 4th Annual
Sep 06, 2007
Displaying 161 - 180 of 229
CONTACT NEWS & EVENTS LEGAL SITE MAP ©2018 Aradigm Corporation. All Rights Reserved.